Researchers and company officials at Avianax are shown in the company's lab at the University of North Dakota in Grand Forks, N.D., Friday, May 30, 2014. They are from left, Bernadette Meberg, chief technician; Dr. David Bradley, UND medical school's chair of microbiology and immunization; Jeremy Vrchota, Avianax sales director and regulatory liaison; and Richard Glynn, the company's chief operating officer. Grand Forks-based Avianax is testing its cure for the canine parvovirus in seven states around the country. Results have shown a 90 percent rate among nearly 50 puppies that have been treated. (AP Photo/Dave Kolpack)
Featured Photo Galleries
